Sveriges mest populära poddar
The Genetics Podcast
VetenskapNaturvetenskap

EP 81: Cracking the druggable genome with Dietrich Stephan, Founder and CEO of NeuBase Therapeutics

43 min•29 juni 2022
This week Patrick is joined by Dietrich Stephan, Founder and CEO of NeuBase Therapeutics. They discuss how to overcome the challenges of ’un-druggable’ diseases, how Neubase is cracking the druggable genome using its scalable technology, and how biotech companies are innovating to secure the investment needed to accelerate precision medicine during a challenging period for the industry.

Fler avsnitt av The Genetics Podcast

Visa alla avsnitt av The Genetics Podcast
EP 233: Unlocking early detection in liver disease with data and genetics with Tim Jobson of Predictive Health Intelligence
•33 min
EP 232: How ethics and law shape reproductive technology and AI in medicine with Glenn Cohen of Harvard Law School
•24 min
EP 231: From polygenic scores to AI-driven medicine with Andrea Ganna of the Institute for Molecular Medicine Finland
•36 min
EP 230: From short reads to long reads in clinical genomics with Anna Lindstrand of Karolinska Institute
•40 min
EP 229: Turning personal tragedy into a movement for preventive genetics with Matthew Goldstein of jscreen
•40 min
EP 228: What genomes reveal about Epstein–Barr virus and human disease with Ryan Dhindsa and Caleb Lareau
•46 min
EP 227: Discovering a new neurodevelopmental syndrome in the non-coding genome with Nicky Whiffin of the University of Oxford
•43 min
EP 226: Scaling AAV gene therapy: Engineering delivery, safety, and cost with David Dismuke of Forge Biologics and Steven Gray of UT Southwestern
•39 min
EP 225: Lessons from 20 years of building ocular gene therapies with Daniel Chung of Beacon Therapeutics
•37 min
EP 224: Genomic newborn screening in Australia: From pilot studies to population-scale programs with Zornitza Stark of the University of Melbourne
•44 min

The Genetics Podcast med Sano Genetics finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.